E-ISSN 2534-9821
 

Case Series 


Ocular Manifestations of mucormycosis in patients of COVID-19

Malvika Sharma, Enakshi Bali, Narain Sharma, Swati Sharma.

Abstract
Mucormycosis is an angioinvasive disease caused by fungi of the order Mucorales like Rhizopus, Mucor, Rhizomucor, Cunninghamella and Absidia. The prevalence of mucormycosis in India is approximately 0.14 cases per 1000 population, about 80 times the prevalence in developed countries. Mucormycosis is a potentially fatal opportunistic infection that can manifest in many clinical forms, including a rhinocerebral form, in the pulmonary system, central nervous system, gastrointestinal system, and other body parts. Rhinocerebral mucormycosis is subdivided into 3 groups: rhinomaxillary, rhino-orbital, and rhino-orbito-cerebral mucormycosis. Extensive forms of the disease include ophthalmia and cranial nerve involvement. Mucormycosis is often seen in immunocompromised individuals, and complications of orbital and cerebral involvement are likely in diabetic ketoacidosis and with the concomitant use of steroids. The most common risk factor associated with mucormycosis is diabetes mellitus in India. Hence, early diagnosis of this potentially life-threatening disease and prompt treatment are important in reducing the mortality rate.
Recently, several cases of mucormycosis in people with COVID-19 have been increasingly reported worldwide, particularly in India. We currently report 4 cases of clinically diagnosed orbital mucormycosis with concurrent COVID-19 illness at our institute over the last 2 months (May and June 2021).

Key words: Pandemic, covid-19, diabetes mellitus, mucormycosis


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Malvika Sharma
Articles by Enakshi Bali
Articles by Narain Sharma
Articles by Swati Sharma
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Sharma M, Bali E, Sharma N, Sharma S. Ocular Manifestations of mucormycosis in patients of COVID-19. Int J Med Rev Case Rep. 2022; 6(11): 23-25. doi:10.5455/IJMRCR.172-1647851300


Web Style

Sharma M, Bali E, Sharma N, Sharma S. Ocular Manifestations of mucormycosis in patients of COVID-19. https://www.mdpub.net/?mno=104236 [Access: December 05, 2023]. doi:10.5455/IJMRCR.172-1647851300


AMA (American Medical Association) Style

Sharma M, Bali E, Sharma N, Sharma S. Ocular Manifestations of mucormycosis in patients of COVID-19. Int J Med Rev Case Rep. 2022; 6(11): 23-25. doi:10.5455/IJMRCR.172-1647851300



Vancouver/ICMJE Style

Sharma M, Bali E, Sharma N, Sharma S. Ocular Manifestations of mucormycosis in patients of COVID-19. Int J Med Rev Case Rep. (2022), [cited December 05, 2023]; 6(11): 23-25. doi:10.5455/IJMRCR.172-1647851300



Harvard Style

Sharma, M., Bali, . E., Sharma, . N. & Sharma, . S. (2022) Ocular Manifestations of mucormycosis in patients of COVID-19. Int J Med Rev Case Rep, 6 (11), 23-25. doi:10.5455/IJMRCR.172-1647851300



Turabian Style

Sharma, Malvika, Enakshi Bali, Narain Sharma, and Swati Sharma. 2022. Ocular Manifestations of mucormycosis in patients of COVID-19. International Journal of Medical Reviews and Case Reports, 6 (11), 23-25. doi:10.5455/IJMRCR.172-1647851300



Chicago Style

Sharma, Malvika, Enakshi Bali, Narain Sharma, and Swati Sharma. "Ocular Manifestations of mucormycosis in patients of COVID-19." International Journal of Medical Reviews and Case Reports 6 (2022), 23-25. doi:10.5455/IJMRCR.172-1647851300



MLA (The Modern Language Association) Style

Sharma, Malvika, Enakshi Bali, Narain Sharma, and Swati Sharma. "Ocular Manifestations of mucormycosis in patients of COVID-19." International Journal of Medical Reviews and Case Reports 6.11 (2022), 23-25. Print. doi:10.5455/IJMRCR.172-1647851300



APA (American Psychological Association) Style

Sharma, M., Bali, . E., Sharma, . N. & Sharma, . S. (2022) Ocular Manifestations of mucormycosis in patients of COVID-19. International Journal of Medical Reviews and Case Reports, 6 (11), 23-25. doi:10.5455/IJMRCR.172-1647851300